BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3405 related articles for article (PubMed ID: 23743292)

  • 21. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
    Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
    PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parkinson's disease in a dish - Using stem cells as a molecular tool.
    Badger JL; Cordero-Llana O; Hartfield EM; Wade-Martins R
    Neuropharmacology; 2014 Jan; 76 Pt A():88-96. PubMed ID: 24035919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of oxidative stress in Parkinson's disease.
    Dias V; Junn E; Mouradian MM
    J Parkinsons Dis; 2013; 3(4):461-91. PubMed ID: 24252804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pale body-like inclusion formation and neurodegeneration following depletion of 26S proteasomes in mouse brain neurones are independent of α-synuclein.
    Paine SM; Anderson G; Bedford K; Lawler K; Mayer RJ; Lowe J; Bedford L
    PLoS One; 2013; 8(1):e54711. PubMed ID: 23382946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.
    Paumier KL; Luk KC; Manfredsson FP; Kanaan NM; Lipton JW; Collier TJ; Steece-Collier K; Kemp CJ; Celano S; Schulz E; Sandoval IM; Fleming S; Dirr E; Polinski NK; Trojanowski JQ; Lee VM; Sortwell CE
    Neurobiol Dis; 2015 Oct; 82():185-199. PubMed ID: 26093169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease.
    Hou X; Fiesel FC; Truban D; Castanedes Casey M; Lin WL; Soto AI; Tacik P; Rousseau LG; Diehl NN; Heckman MG; Lorenzo-Betancor O; Ferrer I; Arbelo JM; Steele JC; Farrer MJ; Cornejo-Olivas M; Torres L; Mata IF; Graff-Radford NR; Wszolek ZK; Ross OA; Murray ME; Dickson DW; Springer W
    Autophagy; 2018; 14(8):1404-1418. PubMed ID: 29947276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Geraniol attenuates α-synuclein expression and neuromuscular impairment through increase dopamine content in MPTP intoxicated mice by dose dependent manner.
    Rekha KR; Selvakumar GP; Santha K; Inmozhi Sivakamasundari R
    Biochem Biophys Res Commun; 2013 Nov; 440(4):664-70. PubMed ID: 24103762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease.
    Ryan BJ; Hoek S; Fon EA; Wade-Martins R
    Trends Biochem Sci; 2015 Apr; 40(4):200-10. PubMed ID: 25757399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators.
    Weinreb O; Mandel S; Youdim MBH; Amit T
    Free Radic Biol Med; 2013 Sep; 62():52-64. PubMed ID: 23376471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current perspective of mitochondrial biology in Parkinson's disease.
    Ammal Kaidery N; Thomas B
    Neurochem Int; 2018 Jul; 117():91-113. PubMed ID: 29550604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.
    Ferrer I; Martinez A; Blanco R; Dalfó E; Carmona M
    J Neural Transm (Vienna); 2011 May; 118(5):821-39. PubMed ID: 20862500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production.
    Tapias V; Hu X; Luk KC; Sanders LH; Lee VM; Greenamyre JT
    Cell Mol Life Sci; 2017 Aug; 74(15):2851-2874. PubMed ID: 28534083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease.
    Alvarez-Erviti L; Seow Y; Schapira AH; Rodriguez-Oroz MC; Obeso JA; Cooper JM
    Cell Death Dis; 2013 Mar; 4(3):e545. PubMed ID: 23492776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial dysfunction and biogenesis in the pathogenesis of Parkinson's disease.
    Lin TK; Liou CW; Chen SD; Chuang YC; Tiao MM; Wang PW; Chen JB; Chuang JH
    Chang Gung Med J; 2009; 32(6):589-99. PubMed ID: 20035637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson's disease.
    Brazdis RM; Alecu JE; Marsch D; Dahms A; Simmnacher K; Lörentz S; Brendler A; Schneider Y; Marxreiter F; Roybon L; Winner B; Xiang W; Prots I
    Hum Mol Genet; 2020 May; 29(7):1180-1191. PubMed ID: 32160287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathogenesis of sporadic Parkinson's disease: contribution of genetic and environmental risk factors].
    Takahashi R; Kawamata J; Takeuchi H
    Rinsho Shinkeigaku; 2009 Nov; 49(11):885-7. PubMed ID: 20030238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate.
    Faustini G; Longhena F; Bruno A; Bono F; Grigoletto J; La Via L; Barbon A; Casiraghi A; Straniero V; Valoti E; Costantino G; Benfenati F; Missale C; Pizzi M; Spillantini MG; Bellucci A
    Neurobiol Dis; 2020 May; 138():104789. PubMed ID: 32032728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys.
    Recasens A; Dehay B; Bové J; Carballo-Carbajal I; Dovero S; Pérez-Villalba A; Fernagut PO; Blesa J; Parent A; Perier C; Fariñas I; Obeso JA; Bezard E; Vila M
    Ann Neurol; 2014 Mar; 75(3):351-62. PubMed ID: 24243558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Voltage-dependent anion channel involved in the α-synuclein-induced dopaminergic neuron toxicity in rats.
    Lu L; Zhang C; Cai Q; Lu Q; Duan C; Zhu Y; Yang H
    Acta Biochim Biophys Sin (Shanghai); 2013 Mar; 45(3):170-8. PubMed ID: 23291291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 171.